+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurovascular Neurology Devices Market - Global Forecast 2026-2032- Product Image
Neurovascular Neurology Devices Market - Global Forecast 2026-2032- Product Image
Sale

Neurovascular Neurology Devices Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968617
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurovascular Neurology Devices Market is projected to reach USD 4.78 Billion in 2026. It is expected to continue growing at a CAGR of 5.46%, reaching USD 6.65 Billion by 2032.

Neurovascular neurology devices are central to modern stroke and cerebrovascular care, covering mechanical thrombectomy systems, aspiration catheters, stent retrievers, flow diverters, embolic coils, carotid stents, neurovascular access devices, and adjunctive imaging-enabled tools. Demand is anchored by the global burden of stroke, which the World Health Organization identifies as a leading cause of death and long-term disability, and by clinical evidence showing that rapid reperfusion improves outcomes in eligible ischemic stroke patients.

The market is increasingly shaped by hospital stroke networks, comprehensive stroke center expansion, minimally invasive endovascular procedures, and guideline-supported treatment pathways. Manufacturers that combine device performance, physician training, real-world evidence, regulatory readiness, and workflow integration are best positioned to compete in this high-acuity medical device segment.

Transformative Shifts in the Neurovascular Device Landscape

The competitive landscape is moving from stand-alone devices toward integrated stroke intervention ecosystems. Hospitals are prioritizing faster door-to-imaging and door-to-reperfusion workflows, creating demand for devices that support navigability, clot engagement, vessel preservation, and procedural efficiency. Clinical practice has also shifted toward broader use of endovascular therapy in selected large vessel occlusion cases, supported by major randomized trials and professional society guidelines.

At the same time, reimbursement scrutiny, regulatory evidence expectations, and procurement standardization are raising the bar for adoption. Suppliers must demonstrate safety, efficacy, usability, and economic value across diverse care settings, including hub-and-spoke stroke systems, mobile stroke pathways, and high-volume neurointerventional centers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator in neurovascular care rather than a distant concept. Regulator-cleared and clinically deployed AI imaging tools already assist with suspected large vessel occlusion detection, hemorrhage alerts, perfusion analysis, and care-team notification, helping hospitals reduce diagnostic delays and coordinate thrombectomy-ready pathways.

The cumulative impact is strongest when AI is linked to validated imaging, secure data exchange, and standardized stroke protocols. For device developers and health systems, AI creates opportunities in procedure planning, patient selection, post-market evidence generation, and training analytics, while also requiring governance around bias, explainability, cybersecurity, interoperability, and clinical accountability.

Key Regional Insights

North America remains a leading innovation and adoption region because of established comprehensive stroke centers, mature emergency medical services, regulatory review pathways, clinical trial infrastructure, and high awareness of endovascular stroke intervention. Europe benefits from mature neurology networks, CE-mark device pathways, and strong public hospital systems, while the European Union’s evolving medical device regulation is increasing emphasis on clinical evidence, device traceability, and post-market surveillance.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in stroke systems, specialist training, advanced imaging, and neurointerventional capacity. Latin America is improving access through private hospital investment and public stroke initiatives, led by Brazil and Mexico, although access remains concentrated in major urban centers. The Middle East is strengthening tertiary care capacity across Gulf health systems, supported by hospital modernization and digital health programs. Africa remains underpenetrated, with progress tied to CT and angiography availability, trained workforce development, emergency referral networks, and sustained public health investment.

Key Group Insights

ASEAN markets are gaining relevance as urban hospitals in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines build interventional neurology capability, although access remains uneven outside major cities. GCC countries are investing in tertiary hospitals, digital health, emergency care modernization, and specialist services, making them important adoption hubs for advanced neurovascular devices and AI-enabled stroke workflows.

The European Union supports device uptake through integrated health systems, clinical standardization, cross-border evidence requirements, and stronger post-market surveillance expectations. BRICS countries represent scale opportunities driven by stroke burden, hospital infrastructure expansion, and domestic manufacturing priorities. G7 markets remain central for innovation, reimbursement benchmarks, guideline development, and clinical evidence generation. NATO countries overlap with many high-income markets where emergency care readiness, supply resilience, data protection, and cybersecurity standards increasingly influence procurement and long-term vendor selection.

Key Country Insights

The United States leads in thrombectomy adoption, clinical research, comprehensive stroke center density, and AI-enabled stroke workflow deployment, while Canada emphasizes organized stroke systems, equitable access, and evidence-based care pathways. Mexico and Brazil are expanding access through major metropolitan hospitals and specialist centers, though public-private disparities remain important. In Europe, the United Kingdom, Germany, France, Italy, and Spain have advanced stroke networks supported by public health systems and neurointerventional expertise, while Russia’s market is shaped by regional infrastructure variation, referral complexity, and localization dynamics.

China is scaling domestic innovation, hospital capacity, stroke center development, and advanced imaging access, while India offers high long-term clinical need with persistent affordability, infrastructure, and specialist availability challenges. Japan is supported by advanced imaging, aging-population stroke needs, and specialist expertise. Australia benefits from organized stroke pathways, tele-stroke support, and strong tertiary care coordination, while South Korea combines strong hospital infrastructure, medical technology adoption, digital health readiness, and rapid uptake of advanced interventional procedures.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical differentiation supported by peer-reviewed evidence, real-world registry data, and measurable workflow outcomes. Devices that improve first-pass reperfusion, reduce complications, support distal access, or simplify navigation through complex anatomy can command stronger clinician attention when paired with credible training, simulation support, and post-market validation.

Executives should also build AI-compatible data strategies, strengthen supply chain resilience, and align market access plans with regional reimbursement and procurement realities. Partnerships with stroke networks, imaging providers, hospitals, emergency care teams, and physician educators can accelerate adoption, while localized manufacturing, early regulatory planning, and value-based economic evidence can improve competitiveness in emerging markets.

Research Methodology

A rigorous research methodology for neurovascular neurology devices should combine primary interviews with neurointerventionalists, vascular neurologists, neurosurgeons, emergency physicians, hospital procurement leaders, regulatory experts, payers, and device executives. Secondary validation should draw from peer-reviewed journals, public regulatory databases, clinical guidelines, health authority publications, reimbursement documents, hospital pathway reports, procedure trends, and real-world evidence sources.

Assessment should segment devices by product type, indication, end user, technology, and geography while avoiding unsupported assumptions. Key variables should include stroke incidence and burden, thrombectomy eligibility, imaging availability, trained specialist density, hospital infrastructure, approval timelines, pricing pressure, procurement requirements, safety outcomes, and competitive launches. Triangulation across clinical, commercial, regulatory, and health-system data improves reliability and reduces single-source bias.

Conclusion

The neurovascular neurology devices market is advancing on the strength of clinical evidence, time-sensitive stroke pathways, minimally invasive innovation, and expanding access to interventional care. Adoption is not uniform, but the direction is clear: hospitals and health systems are prioritizing technologies that improve speed, safety, procedural consistency, and patient outcomes in acute and complex neurovascular disease.

The next phase of competition will favor organizations that combine high-performance neurovascular devices with AI-enabled workflows, physician education, real-world evidence, regulatory discipline, and region-specific access strategies. As stroke systems mature worldwide, neurovascular device leaders have a significant opportunity to improve care quality while building durable, evidence-driven positions in the global cerebrovascular care ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neurovascular Neurology Devices Market, by Product
7.1. Introduction
7.2. Balloon Angioplasty Catheters
7.2.1. Compliant Balloons
7.2.2. Noncompliant Balloons
7.3. Embolic Coils
7.3.1. Bare Coils
7.3.2. Coated Coils
7.3.3. Hydrogel Coils
7.4. Flow Diverters
7.4.1. Biodegradable Flow Diverters
7.4.2. Permanent Flow Diverters
7.5. Neurovascular Stents
7.5.1. Balloon-Expandable Stents
7.5.2. Self-Expanding Stents
7.6. Stent Retriever Systems
7.6.1. Solitaire
7.6.2. Trevo
8. Neurovascular Neurology Devices Market, by Indication
8.1. Introduction
8.2. Aneurysm Occlusion
8.2.1. Fusiform Aneurysm
8.2.2. Saccular Aneurysm
8.3. Arteriovenous Malformations
8.4. Hemorrhagic Stroke
8.5. Ischemic Stroke
8.5.1. Anterior Circulation Stroke
8.5.2. Posterior Circulation Stroke
9. Neurovascular Neurology Devices Market, by Technology
9.1. Introduction
9.2. Chemical Thrombolysis
9.3. Flow Diversion
9.4. Mechanical Thrombectomy
9.4.1. Aspiration Catheters
9.4.2. Stent Retrievers
10. Neurovascular Neurology Devices Market, by Patient Age Group
10.1. Introduction
10.2. Pediatric
10.3. Adult
10.4. Geriatric
11. Neurovascular Neurology Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Neurovascular Neurology Devices Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Neurovascular Neurology Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Neurovascular Neurology Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Acandis GmbH
16.3. AngioDynamics, Inc.
16.4. Asahi Intecc Co., Ltd.
16.5. B. Braun Melsungen AG
16.6. Balt USA, LLC
16.7. Boston Scientific Corporation
16.8. Cardinal Health, Inc.
16.9. Cerus Endovascular Ltd.
16.10. Cook Medical LLC
16.11. Endologix LLC
16.12. InspireMD, Inc.
16.13. Integer Holdings Corporation
16.14. Integra LifeSciences Holdings Corporation
16.15. Johnson & Johnson Services, Inc.
16.16. Lepu Medical Technology (Beijing) Co., Ltd.
16.17. Medtronic plc
16.18. Merit Medical Systems, Inc.
16.19. MicroPort Scientific Corporation
16.20. MicroVention, Inc.
16.21. Penumbra, Inc.
16.22. Perflow Medical Ltd.
16.23. Phenox GmbH
16.24. Rapid Medical Ltd.
16.25. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.26. Spiegelberg GmbH & Co. KG
16.27. Stryker Corporation
16.28. Teleflex Incorporated
16.29. Terumo Corporation
16.30. W. L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BALLOON ANGIOPLASTY CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BALLOON ANGIOPLASTY CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BALLOON ANGIOPLASTY CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COMPLIANT BALLOONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COMPLIANT BALLOONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COMPLIANT BALLOONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL NONCOMPLIANT BALLOONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL NONCOMPLIANT BALLOONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL NONCOMPLIANT BALLOONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL EMBOLIC COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL EMBOLIC COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL EMBOLIC COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BARE COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BARE COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BARE COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL COATED COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL COATED COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL COATED COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL HYDROGEL COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL HYDROGEL COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL HYDROGEL COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL FLOW DIVERTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL BIODEGRADABLE FLOW DIVERTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL BIODEGRADABLE FLOW DIVERTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL BIODEGRADABLE FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PERMANENT FLOW DIVERTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PERMANENT FLOW DIVERTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PERMANENT FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL STENT RETRIEVER SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL STENT RETRIEVER SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL STENT RETRIEVER SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SOLITAIRE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SOLITAIRE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SOLITAIRE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TREVO MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TREVO MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TREVO MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ANTERIOR CIRCULATION STROKE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ANTERIOR CIRCULATION STROKE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ANTERIOR CIRCULATION STROKE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL POSTERIOR CIRCULATION STROKE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL POSTERIOR CIRCULATION STROKE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL POSTERIOR CIRCULATION STROKE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CHEMICAL THROMBOLYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CHEMICAL THROMBOLYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CHEMICAL THROMBOLYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL FLOW DIVERSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL FLOW DIVERSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL FLOW DIVERSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL STENT RETRIEVERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL STENT RETRIEVERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL STENT RETRIEVERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 158. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 159. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 160. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 161. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 162. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 163. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 164. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 165. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 166. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 168. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 169. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 186. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 187. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 188. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 189. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 190. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 191. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 192. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 193. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 194. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 195. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 196. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 197. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 201. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 202. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 203. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 204. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 205. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 206. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 207. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 208. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 209. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 211. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 212. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 215. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 216. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 217. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 218. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 219. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 220. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 221. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 222. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 223. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 224. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 225. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 226. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 243. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 244. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 245. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 246. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 247. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 248. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 249. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 250. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 251. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 253. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 254. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 256. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 257. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 258. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 259. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 260. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 261. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 262. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 263. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 264. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 265. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 266. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 267. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 268. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 271. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 272. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 273. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 274. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 275. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 276. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 277. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 278. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 279. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 280. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 281. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 282. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 299. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 300. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 301. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 302. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 303. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 304. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 305. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 306. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 307. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 308. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 309. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 310. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 311. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 312. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 314. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2017-2032 (USD MILLION)
TABLE 315. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2017-2032 (USD MILLION)
TABLE 316. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2017-2032 (USD MILLION)
TABLE 317. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 318. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2017-2032 (USD MILLION)
TABLE 319. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 320. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2017-2032 (USD MILLION)
TABLE 321. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2017-2032 (USD MILLION)
TABLE 322. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 323. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2017-2032 (USD MILLION)
TABLE 324. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 325. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL NEUROVAS

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Balt USA, LLC
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cerus Endovascular Ltd.
  • Cook Medical LLC
  • Endologix LLC
  • InspireMD, Inc.
  • Integer Holdings Corporation
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Spiegelberg GmbH & Co. KG
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.65 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Interventional Neurology Devices Market - Global Forecast 2026-2032 - Product Image

Interventional Neurology Devices Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Neurovascular Devices / Interventional Neurology - Global Strategic Business Report - Product Image

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report

  • Report
  • 198 Pages
  • Global
From
Neurology Devices Market - Global Forecast 2026-2032 - Product Image

Neurology Devices Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Neurovascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Neurovascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 - Product Image

Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.